Detalhe da pesquisa
1.
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
Cell
; 185(3): 467-484.e15, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081335
2.
Antibody evasion by the P.1 strain of SARS-CoV-2.
Cell
; 184(11): 2939-2954.e9, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852911
3.
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
Cell
; 184(16): 4220-4236.e13, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34242578
4.
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
Lancet
; 399(10324): 521-529, 2022 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074136
5.
The role of a genetically stable, novel oral type 2 poliovirus vaccine in the poliomyelitis endgame.
Rev Panam Salud Publica
; 47: e99, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37405121
6.
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials.
J Infect Dis
; 226(5): 852-861, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610135
7.
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.
Lancet
; 397(10268): 27-38, 2021 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33308427
8.
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
Lancet
; 397(10268): 39-50, 2021 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33308429
9.
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Lancet
; 397(10277): 881-891, 2021 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617777
10.
Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR.
J Clin Microbiol
; 60(4): e0228321, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35321556
11.
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.
Lancet
; 394(10193): 148-158, 2019 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31174831
12.
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike.
NPJ Vaccines
; 9(1): 7, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38182593
13.
Investigating the Possible Reasons for the Low Reported Morbidity and Mortality of COVID-19 in African Countries: An Integrative Review.
Pediatr Infect Dis J
; 42(7): e222-e228, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37054386
14.
Influenza Vaccination during Pregnancy: A Descriptive Study of the Knowledge, Beliefs, and Practices of Mexican Gynecologists and Family Physicians.
Vaccines (Basel)
; 11(8)2023 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37631951
15.
Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults.
Hum Vaccin Immunother
; 19(2): 2233400, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37438960
16.
Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System.
Drugs Real World Outcomes
; 9(1): 79-90, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34510402
17.
Economic Evaluation of Universal Varicella Vaccination in Mexico.
Pediatr Infect Dis J
; 41(5): 439-444, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34966138
18.
Homologous and Heterologous Boosting of the Chadox1-S1-S COVID-19 Vaccine With the SCB-2019 Vaccine Candidate: A Randomized, Controlled, Phase 2 Study.
Open Forum Infect Dis
; 9(8): ofac418, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36043184
19.
Effectiveness of the Fiocruz recombinant ChadOx1-nCoV19 against variants of SARS-CoV-2 in the Municipality of Botucatu-SP.
Front Public Health
; 10: 1016402, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36311567
20.
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
EBioMedicine
; 81: 104128, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35779491